{
  "meta": {
    "title": "00181_Mid_Day_Pyqs_Neetpg-22",
    "url": "https://brainandscalpel.vercel.app/00181-mid-day-pyqs-neetpg-22-1b343c40.html",
    "scrapedAt": "2025-11-29T18:13:53.896Z"
  },
  "questions": [
    {
      "id": 72568,
      "choices": [
        {
          "id": 289261,
          "text": "<p><span style=\"font-size:16px;\">Day -1</span></p>"
        },
        {
          "id": 289262,
          "text": "<p><span style=\"font-size:16px;\">2-3 days</span></p>"
        },
        {
          "id": 289263,
          "text": "<p><span style=\"font-size:16px;\">4-7 days</span></p>"
        },
        {
          "id": 289264,
          "text": "<p><span style=\"font-size:16px;\">&gt;7 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A boy fell while playing and suffered an abrasion injury on his knees. The dark brown scab will be seen in how many days? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q8749576",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979955,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) 4-7 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Abrasions heal in a <strong>predictable manner</strong>, forming a <strong>scab</strong> due to <strong>drying of blood, serum, and tissue fluids</strong>. The <strong>color of the scab changes over time</strong>, providing a reliable estimate of injury duration:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Timeline of Scab Formation in Abrasions</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Day 1 (Fresh wound)</strong> → <strong>Bright red</strong> due to <strong>oozing blood &amp; lymph</strong>.</span></li><li><span style=\"font-size:16px;\"><strong>12-24 hours</strong> → <strong>Reddish scab</strong> begins to form.</span></li><li><span style=\"font-size:16px;\"><strong>2-3 days</strong> → <strong>Reddish-brown scab</strong> develops.</span></li><li><span style=\"font-size:16px;\"><strong>4-7 days</strong> → <strong>Dark brown to black scab</strong> appears as the wound dries​</span></li><li><span style=\"font-size:16px;\"><strong>&gt;7 days</strong> → <strong>Scab begins to peel off</strong>, leaving a <strong>depigmented area</strong> that gradually fades.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Day 1:&nbsp; </strong>Incorrect.<strong> </strong>Fresh abrasion will appear <strong>bright red</strong> with <strong>oozing blood and lymph</strong>, not a dark brown scab.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. 2-3 days:&nbsp; </strong>Incorrect.<strong> </strong>Scab forms but is <strong>reddish-brown</strong>, not dark brown.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. &gt;7 days:&nbsp; </strong>Incorrect.<strong> </strong>By <strong>&gt;7 days</strong>, the <strong>scab starts falling off</strong>, revealing <strong>new epithelium</strong> underneath.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\"><strong>Age of Abrasion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-25%20135610.jpg\" width=\"1054\" height=\"520\"></strong></span></p>",
      "correct_choice_id": 289263,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72568/FMGE_Jan_2025_Forensic_Medicine_Q_-_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72568/FMGE_Jan_2025_Forensic_Medicine_Q_-_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73060,
      "choices": [
        {
          "id": 291205,
          "text": "<p><span style=\"font-size:16px;\">Direct</span></p>"
        },
        {
          "id": 291206,
          "text": "<p><span style=\"font-size:16px;\">Arterial</span></p>"
        },
        {
          "id": 291207,
          "text": "<p><span style=\"font-size:16px;\">Venous</span></p>"
        },
        {
          "id": 291208,
          "text": "<p><span style=\"font-size:16px;\">Lymphatic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Spread of prostate cancer to lumbar vertebra occurs via? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q4587948",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979956,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Venous</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Prostate cancer spreads to lumbar vertebrae through:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Bateson's venous plexus (vertebral venous plexus)</span></li><li><span style=\"font-size:16px;\">This is a valveless system allowing bidirectional flow</span></li><li><span style=\"font-size:16px;\">Connects prostatic venous plexus to vertebral veins</span></li><li><span style=\"font-size:16px;\">Most common cancer in men with bone metastasis</span></li><li><span style=\"font-size:16px;\">Typically produces osteoblastic lesions in bones</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Direct</strong>: Incorrect as prostate is anatomically distant from lumbar vertebrae making direct spread impossible</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Arterial</strong>: Incorrect as prostatic venous plexus connection to vertebrae via Bateson's plexus is the established pathway</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Lymphatic</strong>: Incorrect as lymphatic spread of prostate cancer is typically to pelvic and para-aortic nodes, not directly to vertebrae</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Prostate cancer spreads to lumbar vertebrae through Bateson's venous plexus, making it the most common cancer in men with bone metastasis.</span></p><p><br><br><span style=\"font-size:16px;\"><strong>Spread of CA Prostate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-28%20132412.jpg\" width=\"879\" height=\"412\"></strong></span></p>",
      "correct_choice_id": 291207,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73060/FMGE_Jan_2025_Surgery_Q_-13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73060/FMGE_Jan_2025_Surgery_Q_-13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31891,
      "choices": [
        {
          "id": 127434,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Target cell</span></span></span></p>"
        },
        {
          "id": 127435,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hairy cell </span></span></span></p>"
        },
        {
          "id": 127436,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gaucher cell </span></span></span></p>"
        },
        {
          "id": 127437,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sickle cell</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Below is an electron microscopy depiction of a cellular structure. Determine the type of cell being depicted. (NEET PG 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-194200.jpg\" style=\"height:268px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q6520574",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979959,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Hairy cell </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hairy cells are seen in Hairy cell leukemia. It is a B-cell tumor. Peripheral smear shows pancytopenia; hairy cells. Flow cytometry shows CD11/25/103 + cells. Annexin &ndash;A is the best marker.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Target cell:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> can be seen in&nbsp;thalassemia, hepatic disease with jaundice, hemoglobin C disorders, and the post splenectomy state.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-194237.jpg\" style=\"height:216px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gaucher cell:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is found in Gaucher&rsquo;s disease which occurs due to absence of beta glucocerebrosidase enzyme.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-194314.jpg\" style=\"height:222px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sickle cells: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;are seen in sickle cell anemia. HbS has altered solubility and high chance of polymer formation especially with dehydration</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> or hypoxemia causing alteration in shape. On rehydration, it is reversible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hairy cells are seen in hairy cell leukemia, characterized by B lymphocytes with hair-like projections, and are identified using electron microscopy and specific markers like CD11c, CD25, CD103, and Annexin-A.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-194348.jpg\" style=\"height:240px; width:300px\" /></span></span></span></p>",
      "correct_choice_id": 127435,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13781,
      "choices": [
        {
          "id": 55085,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal</span></p>"
        },
        {
          "id": 55086,
          "text": "<p><span style=\"font-size:12.0pt;\">Adult ovary</span></p>"
        },
        {
          "id": 55087,
          "text": "<p><span style=\"font-size:12.0pt;\">Prepubertal testis</span></p>"
        },
        {
          "id": 55088,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothalamus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following locations does meiosis normally occur in the human body? (NEET PG 2020)</span></p>",
      "unique_key": "Q5482797",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979949,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Adult ovary</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Meiosis occurs in the adult ovary.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Meiosis is the process by which gametes (sperm and eggs) are produced in sexually reproducing organisms.</span></li><li><span style=\"font-size:12.0pt;\">It occurs only in germ cells and leads to the formation of haploid gametes.</span></li><li><span style=\"font-size:12.0pt;\">To reduce the number of chromosomes to the haploid number of 23, meiosis requires two cell divisions, meiosis I and meiosis II.</span></li><li><span style=\"font-size:12.0pt;\">In females, meiosis occurs in the ovaries during fetal development, but is arrested in prophase I until puberty.</span></li><li><span style=\"font-size:12.0pt;\">After puberty, meiosis resumes and one ovum is produced each month.</span></li><li><span style=\"font-size:12.0pt;\">In males, meiosis occurs in the testes and produces sperm.</span></li><li><span style=\"font-size:12.0pt;\">Meiosis in the testes begins during puberty and continues throughout adulthood.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-880.jpg\" alt=\"\" width=\"500\" height=\"315\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Adrenal</strong>: The adrenal glands are located atop each kidney and are involved in the production of various hormones, such as cortisol, aldosterone, and sex steroids. Meiosis, the process by which germ cells divide to produce gametes with half the number of chromosomes, does not occur in the adrenal glands. Instead, the adrenal glands are involved in steroidogenesis or the production of steroid hormones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Prepubertal testis</strong>: The testes are the male reproductive organs that produce spermatozoa (sperm cells) and testosterone. In males, meiosis begins during puberty. In the prepubertal testis, the germ cells are not yet undergoing meiosis to form mature sperm cells. These germ cells (spermatogonia) proliferate by mitosis during childhood but only enter meiosis to become spermatocytes and eventually mature spermatozoa after the onset of puberty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Hypothalamus</strong>: It is a region of the brain responsible for various vital functions, including the release of hormones that regulate the pituitary gland. It is not involved in meiosis. Instead, it plays an essential role in regulating various physiological processes, such as body temperature, thirst, hunger, and circadian rhythms. It also plays a significant role in controlling the release of hormones from the anterior pituitary by producing releasing or inhibiting hormones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Adult ovaries </strong>are responsible for producing ova (egg cells) and hormones such as estrogen and progesterone. Meiosis begins in the fetal ovaries but is <strong>arrested in prophase I</strong> until puberty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">After puberty, with each menstrual cycle, some oocytes resume meiosis, completing meiosis I and arresting in meiosis II. <strong>It's only after fertilization that meiosis II completes</strong>. Therefore, meiosis occurs in the adult ovary as it is essential for the formation of mature ova or egg cells.</span></p>",
      "correct_choice_id": 55086,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5138,
      "choices": [
        {
          "id": 20525,
          "text": "<p><span style=\"font-size:12.0pt;\">CTS: Froment sign</span></p>"
        },
        {
          "id": 20526,
          "text": "<p><span style=\"font-size:12.0pt;\">CTS: Durkan test</span></p>"
        },
        {
          "id": 20527,
          "text": "<p><span style=\"font-size:12.0pt;\">Guyon canal syndrome: Froment sign</span></p>"
        },
        {
          "id": 20528,
          "text": "<p><span style=\"font-size:12.0pt;\">Guyon canal syndrome: Durkan test</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient complains that he often gets troubled at night during sleep by tingling and numbness that involves his lateral three digits. He further explains that symptoms are relieved as he lays his arms hanging from the bed. Correct regarding the condition is:&nbsp;(NEET PG 2023)</span></p>",
      "unique_key": "Q2285462",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979952,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) CTS: Durkan test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CARPAL TUNNEL SYNDROME</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is the entrapment of median nerve at the wrist beneath the flexor retinaculum</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">8 times more common in females</span></li><li><span style=\"font-size:12.0pt;\">Usual age group is 50 years</span></li><li><span style=\"font-size:12.0pt;\">Burning pain, paresthesia, tingling and numbness in median nerve distribution</span><br><br><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture41.jpg\" alt=\"\" width=\"300\" height=\"180\"><br><br>&nbsp;</li><li><span style=\"font-size:12.0pt;\">Pain increased by activities, more troublesome at night; relieved by handing the arm over the side of bed or by shaking the arm</span></li><li><span style=\"font-size:12.0pt;\">Clumsiness and weakness in tasks requiring fine manipulation</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Special tests:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Sensory symptoms can be reproduced by percussion over the median nerve – <strong>Tinel’s sign</strong></span></li><li><span style=\"font-size:12.0pt;\">Sensory symptoms can also be reproduced by holding the wrist in full flexion for a minute – <strong>Phalen’s test/Reverse Phalen’s test</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture37.jpg\" alt=\"\" width=\"300\" height=\"235\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Phalen’s test; 2. Reverse Phalen’s test</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The most specific test for carpal tunnel syndrome is <strong>Durkans test</strong> – Direct compression over the median nerve – best clinical test – done by holding wrist in slight flexion and directly compressing the nerve by applying pressure to proximal wrist crease for 30 seconds – development of pain, paresthesia or numbness indicates a positive test.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture38.jpg\" alt=\"\" width=\"300\" height=\"325\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CTS: Froment sign.&nbsp;</strong>Froment’s sign is seen in cases of ulnar nerve palsy where the adductor pollicis is paralysed. The patient is made to hold a book between the thumb and the palm. In case of ulnar nerve palsy, the patient will hold the book using the flexor pollicis longus muscle, which will produce flexion at the IP joint.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture39.jpg\" alt=\"\" width=\"500\" height=\"215\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This sign is specific of ulnar nerve palsy and will be negative in carpal tunnel syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Guyon canal syndrome: Froment sign.&nbsp;</strong>Guyon Canal syndrome, also known as <strong>Ulnar Tunnel Syndrome/ulnar tunnel syndrome/handlebar palsy,</strong> is a relatively rare peripheral ulnar neuropathy. It is defined as a compression of the distal&nbsp;ulnar nerve&nbsp;at the level of the wrist as it enters the hand through a space called <strong>ulnar tunnel or&nbsp;Guyon canal</strong>. The clinical presentation can be purely sensory, purely motor or both depending on the location of the nerve compression. Froment’s sign will be positive in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Guyon canal syndrome: Durkan test.&nbsp;</strong>Durkan test is the most specific and sensitive for carpal tunnel syndrome only.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given clinical symptoms of the patient suggest presence of carpal tunnel syndrome. The most specific test to check median nerve compression in the carpal tunnel is the Durkan’s Test.</span></li></ul>",
      "correct_choice_id": 20526,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20336,
      "choices": [
        {
          "id": 81305,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in length by 25 cm in the first year</span></p>"
        },
        {
          "id": 81306,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight gain of 300 grams per month till 1 year</span></p>"
        },
        {
          "id": 81307,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior fontanelle closure by 6 months of age</span></p>"
        },
        {
          "id": 81308,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight under 75th percentile and height under 25th percentile</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the correct sign indicating adequate growth in an infant with a birth weight of 3 kg? (NEET PG 2023)</span></p>",
      "unique_key": "Q8903637",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979958,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Increase in length by 25 cm in the first year</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Correct sign to indicate adequate growth in an infant is an increase in length of 25 cm in the first year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal length of a newborn - 48-50cm (increase by 50% at 1st year = 75cm)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-151425.png\" alt=\"\" width=\"1000\" height=\"261\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Weight gain of 300 grams per month till 1 year</strong>: An infant gain weight at a rate of approximately 20-40 g per day for the first 3 months of life. Thereafter, they gain about 400 g weight every month for the remaining part of the first year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anterior fontanelle closure by 6 months of age:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-151608.png\" alt=\"\" width=\"1000\" height=\"347\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Weight under 75th percentile and height under 25th percentile</strong>: According to WHO growth charts, weight and height under 50<sup>th</sup> percentile do not indicate adequate growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An increase in length by 25 cm in the first year is a key indicator of adequate growth in infants.</span></p>",
      "correct_choice_id": 81305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55348,
      "choices": [
        {
          "id": 220853,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IV Labetalol</span></span></p>"
        },
        {
          "id": 220854,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IV Nitroglycerin</span></span></p>"
        },
        {
          "id": 220855,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oral Nifedipine</span></span></p>"
        },
        {
          "id": 220856,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IV Hydralazine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 50-year-old male patient presents with headache and seizures. On examination his BP is 220/110 mm Hg. What is the most appropriate treatment? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q5444878",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979940,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) IV Labetalol</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this case, the patient is experiencing a <strong>neurological hypertensive emergency</strong>, as indicated by his headache and seizures alongside a high blood pressure reading of 220/110 mm Hg. This condition could stem from several serious issues, including ischemic stroke, intracranial hemorrhage, or hypertensive encephalopathy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The primary objective in managing a neurological hypertensive emergency is to safely reduce the blood pressure. For such emergencies, <strong>the first-line treatments typically include IV Nicardipine or IV Labetalol.</strong> Given that IV nicardipine is often not available in many Indian hospitals, IV labetalol becomes the preferred option, making it the <strong>Ans.</strong> in this scenario.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. IV Nitroglycerin:</strong> Nitrates, such as nitroglycerin, are generally avoided in neurological emergencies because they cause vasodilation, which can increase cerebral blood flow. This increase in blood flow can elevate intracranial pressure, potentially worsening the patient&#39;s condition.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Oral Nifedipine:</strong> Oral medications are not suitable for emergency situations due to their delayed onset of action. Immediate reduction of blood pressure is crucial in this case, making oral nifedipine inappropriate.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. IV Hydralazine:</strong> Although IV hydralazine is an arterial vasodilator, it is not recommended for neurological hypertensive emergencies. Similar to nitrates, it can lead to an increase in intracranial pressure and potentially exacerbate the patient&#39;s symptoms.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In neurological hypertensive emergencies, the first-line treatment options for reducing blood pressure are IV nicardipine or IV labetalol, with IV labetalol being preferred if IV nicardipine is unavailable.</span></span></p>",
      "correct_choice_id": 220853,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55419,
      "choices": [
        {
          "id": 221137,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Iron deficiency anemia</span></span></p>"
        },
        {
          "id": 221138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anemia of chronic disease</span></span></p>"
        },
        {
          "id": 221139,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aplastic anemia</span></span></p>"
        },
        {
          "id": 221140,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myelodysplastic syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 65-year-old female presented with anemia. What is the most common cause? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q6158784",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979945,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Iron deficiency anemia</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Iron deficiency anemia is the most common cause of anemia across all age groups, including older adults. It occurs when the body&#39;s iron stores are depleted, leading to reduced production of hemoglobin and red blood cells. This condition is especially common in older adults due to factors such as poor dietary intake, gastrointestinal bleeding, and malabsorption.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In elderly patients, it is crucial to rule out underlying causes of iron deficiency anemia, particularly gastrointestinal malignancies such as colorectal cancer. For postmenopausal women and elderly men presenting with anemia, investigations such as colonoscopy or fecal occult blood tests are important to identify or exclude potential sources of chronic blood loss.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Anemia of chronic disease</strong>: This type of anemia is common in patients with chronic infections, inflammatory diseases, or malignancies, but it is not the most common cause of anemia in the general elderly population.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>Aplastic anemia: </strong>&nbsp;A rare condition characterized by pancytopenia and bone marrow failure. It is not a common cause of anemia in the elderly.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>Myelodysplastic syndrome: </strong>&nbsp;A group of disorders caused by poorly formed or dysfunctional blood cells, more common in older adults, but not as prevalent as iron deficiency anemia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Iron deficiency anemia is the most common cause of anemia, especially in elderly patients, and requires thorough evaluation to rule out serious underlying conditions such as gastrointestinal malignancies.</span></span></p>",
      "correct_choice_id": 221137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20258,
      "choices": [
        {
          "id": 80993,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 80994,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 80995,
          "text": "<p><span style=\"font-size:12.0pt;\">Esmolol</span></p>"
        },
        {
          "id": 80996,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents with severe restlessness, palpitations, and tremors to the emergency department. She is a known case of bronchial asthma. On examination, the neck looks swollen. Blood pressure is elevated, and tachycardia is noted. ECG shows atrial fibrillation. Which of the following drugs is used for immediate management in this patient? (NEET PG 2023)</span></p>",
      "unique_key": "Q1754187",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979943,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Diltiazem</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with atrial fibrillation and bronchial asthma, the primary goal is to control the heart rate. For rate control in atrial fibrillation, beta-blockers and non-dihydropyridine calcium channel blockers (NDCCBs) like diltiazem or verapamil are commonly used. However, in this case, the patient has bronchial asthma, which makes the use of beta-blockers (such as propranolol and esmolol) less suitable due to their potential to exacerbate asthma symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diltiazem is a non-dihydropyridine calcium channel blocker that effectively controls the heart rate without affecting bronchial muscle tone, making it a safer option for patients with asthma. Therefore, diltiazem is the drug of choice for immediate management in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Propranolol:</strong> Propranolol is a beta-blocker, which can exacerbate bronchial asthma by causing bronchoconstriction. Thus, it is not a suitable choice for patients with asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Esmolol:</strong> Similar to propranolol, esmolol is a beta-blocker and can worsen asthma symptoms due to its bronchoconstrictive effects, making it unsuitable for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Propylthiouracil:</strong> This medication is used in the management of thyroid storm, a condition associated with severe hyperthyroidism. It is not relevant for rate control in atrial fibrillation and does not address the immediate needs of this patient's condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For immediate rate control in atrial fibrillation in a patient with bronchial asthma, non-dihydropyridine calcium channel blockers like diltiazem are preferred over beta-blockers to avoid exacerbating asthma symptoms.</span></p>",
      "correct_choice_id": 80993,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73634,
      "choices": [
        {
          "id": 293477,
          "text": "<p><span style=\"font-size:16px;\">Rb</span></p>"
        },
        {
          "id": 293478,
          "text": "<p><span style=\"font-size:16px;\">p53</span></p>"
        },
        {
          "id": 293479,
          "text": "<p><span style=\"font-size:16px;\">C-myc</span></p>"
        },
        {
          "id": 293480,
          "text": "<p><span style=\"font-size:16px;\">K RAS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A young patient presents with rapidly growing lymph nodes around the jaw. His biopsy confirms the diagnosis of Burkitt's lymphoma. Which gene mutation is most commonly implicated in this condition? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q1088364",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979954,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) C-myc</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Burkitt's lymphoma is characterized by translocation involving the C-myc proto-oncogene. The most common translocation is t(8;14), which places the C-myc gene (located on chromosome 8) under the control of immunoglobulin heavy chain enhancers (located on chromosome 14). Less commonly, translocations t(2;8) or t(8;22) may occur. These translocations result in overexpression of the C-myc proto-oncogene, leading to uncontrolled cell proliferation.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rb:&nbsp;</strong>Incorrect. The Rb (Retinoblastoma) gene is a tumor suppressor gene located on chromosome 13q14. Mutations in this gene are associated with retinoblastoma, not Burkitt's lymphoma. Rb gene inactivation is also found in other cancers like osteosarcoma and small cell lung carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. p53:</strong> Incorrect. The p53 gene is often called the <strong>\"guardian of the genome</strong>\" and is a key tumor suppressor gene. While p53 mutations are common in many cancers, they are not the characteristic genetic alteration in Burkitt's lymphoma. p53 mutations are more commonly associated with Li-Fraumeni syndrome and play a role in many sporadic cancers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. K-RAS:&nbsp;</strong>Incorrect. K-RAS gene mutations are commonly associated with cancers of the gastrointestinal tract, particularly colorectal and pancreatic cancers. They are not typically implicated in the pathogenesis of Burkitt's lymphoma. K-RAS mutations lead to constitutive activation of the RAS signaling pathway, resulting in uncontrolled cell growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Burkitt's lymphoma is characterized by translocation of the <strong>C-myc proto-oncogene</strong>, most commonly t(8;14), resulting in overexpression of C-myc and rapid cellular proliferation.</span></p>",
      "correct_choice_id": 293479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55402,
      "choices": [
        {
          "id": 221069,
          "text": "<p><span style=\"font-size:12pt;\">Neurofibromatosis</span></p>"
        },
        {
          "id": 221070,
          "text": "<p><span style=\"font-size:12pt;\">Tuberous sclerosis</span></p>"
        },
        {
          "id": 221071,
          "text": "<p><span style=\"font-size:12pt;\">Sturge-Weber syndrome</span></p>"
        },
        {
          "id": 221072,
          "text": "<p><span style=\"font-size:12pt;\">Von Hippel Lindau syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient presented with 2 Lisch nodules in the iris. What is the possible diagnosis? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2993866",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979946,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Neurofibromatosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Lisch nodules are pigmented, benign hamartomas found in the iris of the eye. They are highly specific to Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease. NF1 is a genetic disorder characterized by the development of multiple benign tumors called neurofibromas, café-au-lait spots, and other neurological and ocular manifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Key diagnostic feature:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Lisch nodules:</strong> These are melanocytic hamartomas and are considered a hallmark of NF1. Their presence, particularly when there are two or more, is diagnostic of NF1.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Tuberous sclerosis:</strong> This genetic disorder is characterized by the growth of benign tumors in multiple organs, including the brain, skin, kidneys, and heart. It is associated with other ocular findings such as retinal hamartomas, but not with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Sturge-Weber syndrome:</strong> This congenital disorder is associated with a port-wine stain birthmark, neurological abnormalities, and ocular issues like glaucoma, but not with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Von Hippel Lindau syndrome:</strong> This is a genetic disorder that leads to the formation of tumors and cysts in different parts of the body, particularly the kidneys, pancreas, and central nervous system. It is not associated with Lisch nodules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of Lisch nodules in the iris is highly specific for Neurofibromatosis type 1 (NF1), making it a key diagnostic feature for this condition</span></p>",
      "correct_choice_id": 221069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14005,
      "choices": [
        {
          "id": 55981,
          "text": "<p><span style=\"font-size:12.0pt;\">Exposure keratopathy</span></p>"
        },
        {
          "id": 55982,
          "text": "<p><span style=\"font-size:12.0pt;\">Restricted eye movements</span></p>"
        },
        {
          "id": 55983,
          "text": "<p><span style=\"font-size:12.0pt;\">Diplopia</span></p>"
        },
        {
          "id": 55984,
          "text": "<p><span style=\"font-size:12.0pt;\">Amblyopia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the most common complication associated with the following abnormality? (</span>NEET PG 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-160.jpg\" alt=\"\" width=\"300\" height=\"220\"></span></p>",
      "unique_key": "Q9115371",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979962,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Exposure keratopathy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given image shows a coloboma of the upper eyelid. The most common complication associated with this condition is exposure keratopathy since the defect leaves the cornea exposed. If left untreated, it can lead to corneal ulceration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CONGENITAL EYELID COLOBOMA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Can be unilateral or bilateral, involving one or all four lids.</span></li><li><span style=\"font-size:12.0pt;\">The defect may vary from a small marginal notch to a full-thickness absence of the entire eyelid margin involving one-third to half of the eyelid.</span></li><li><span style=\"font-size:12.0pt;\">The upper eyelid is commonly affected.</span></li><li><span style=\"font-size:12.0pt;\">The most common site is the junction between the medial and middle third of the upper eyelid.</span></li><li><span style=\"font-size:12.0pt;\">Eyelid colobomas represent an incomplete form of cryptophthalmos. Cryptophthalmos is a congenital condition in which there is a failure of differentiation of eyelid structures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Restricted eye movements:&nbsp;</strong>This is not a primary complication of eyelid coloboma. Restricted eye movements are more associated with orbital or extraocular muscle issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diplopia:&nbsp;</strong>Diplopia, or double vision, is not a common complication of eyelid coloboma. It usually arises from misalignment of the eyes or neurological conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amblyopia:&nbsp;</strong>Amblyopia, or lazy eye, can occur due to vision deprivation in severe cases of eyelid abnormalities, but it is not the most common complication of eyelid coloboma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eyelid colobomas can be an isolated finding or can be associated with various syndromes mentioned below:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-192933.png\" alt=\"\" width=\"1000\" height=\"530\"></span></p>",
      "correct_choice_id": 55981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81759,
      "choices": [
        {
          "id": 325700,
          "text": "<p>External iliac artery</p>"
        },
        {
          "id": 325701,
          "text": "<p>Internal iliac artery</p>"
        },
        {
          "id": 325702,
          "text": "<p>Femoral artery</p>"
        },
        {
          "id": 325703,
          "text": "<p>Thoracic artery</p>"
        }
      ],
      "text": "<p>The inferior epigastric artery originates from which of the following arteries? (NEET PG 2015)</p>",
      "unique_key": "Q8169220",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979938,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><strong>Answer: A. External iliac artery</strong></p><p>&nbsp;</p><p>The inferior epigastric artery originates from the external iliac artery just above the inguinal ligament near the lower end. It runs upwards and medially in the extraperitoneal connective tissue, passes just medial to the deep inguinal ring, pierces the fascia transversalis at the lateral border of the rectus abdominis, and enters the rectus sheath by passing in front of the arcuate line. Within the sheath, it supplies the rectus muscle and ends by anastomosing with the superior epigastric artery.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Internal iliac artery</strong> - This artery gives rise to branches that supply pelvic viscera and the gluteal region, but it does not give rise to the inferior epigastric artery. The internal iliac artery provides branches like the superior and inferior gluteal arteries, internal pudendal artery, and obturator artery.</p><p>&nbsp;</p><p><strong>Option C. Femoral artery</strong> - The femoral artery is the continuation of the external iliac artery below the inguinal ligament. It supplies the lower limb and gives branches like the superficial epigastric artery (not the inferior epigastric), but not the inferior epigastric artery.</p><p>&nbsp;</p><p><strong>Option D. Thoracic artery</strong> - The thoracic artery (likely referring to the internal thoracic/internal mammary artery) gives rise to the superior epigastric artery, not the inferior epigastric. The superior epigastric artery anastomoses with the inferior epigastric artery.</p><p>&nbsp;</p><p><strong>Educational Objective</strong>:&nbsp;</p><p>&nbsp;</p><p>The inferior epigastric artery is a branch of the external iliac artery that runs upward in the anterior abdominal wall to supply the rectus abdominis muscle and forms an important anastomosis with the superior epigastric artery, creating a connection between the subclavian and external iliac arterial systems.</p>",
      "correct_choice_id": 325700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73671,
      "choices": [
        {
          "id": 293625,
          "text": "<p><span style=\"font-size:16px;\">It replenishes glutathione levels</span></p>"
        },
        {
          "id": 293626,
          "text": "<p><span style=\"font-size:16px;\">It inhibits the cytochrome P450 enzyme responsible for NAPQI formation</span></p>"
        },
        {
          "id": 293627,
          "text": "<p><span style=\"font-size:16px;\">It acts as a direct antioxidant to neutralize NAPQI</span></p>"
        },
        {
          "id": 293628,
          "text": "<p><span style=\"font-size:16px;\">It enhances renal clearance of NAPQI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">What is the mechanism of action of N-acetylcysteine in paracetamol toxicity?&nbsp;(FMGE JAN 2025)</span></p>",
      "unique_key": "Q8888726",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979961,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) It replenishes glutathione levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">N-acetylcysteine works by replenishing glutathione levels in paracetamol toxicity. Paracetamol is metabolized by cytochrome P450 enzymes to form NAPQI (N-acetyl-para-benzoquinoneimine), which is a toxic metabolite.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Normally, glutathione in the liver neutralizes NAPQI. However, toxicity occurs in three scenarios:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">High doses of paracetamol leading to excessive NAPQI formation</span></li><li><span style=\"font-size:16px;\">Chronic alcoholism causing increased CYP enzyme activity</span></li><li><span style=\"font-size:16px;\">Liver disease reducing glutathione production</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">N-acetylcysteine is converted to glutathione, which then binds and neutralizes NAPQI. For maximum effectiveness, N-acetylcysteine should be administered within 8 hours of paracetamol ingestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. It inhibits the cytochrome P450 enzyme responsible for NAPQI formation: Incorrect -</strong> N-acetylcysteine does not inhibit cytochrome P450 enzymes. It works by replenishing glutathione which neutralizes NAPQI after its formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. It acts as a direct antioxidant to neutralize NAPQI: Incorrect -&nbsp;</strong>N-acetylcysteine does not directly neutralize NAPQI. It is first converted to glutathione, which then neutralizes NAPQI.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. It enhances renal clearance of NAPQI: Incorrect -&nbsp;</strong>N-acetylcysteine does not enhance renal clearance of NAPQI. Its mechanism involves glutathione replenishment.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">N-acetylcysteine is the antidote for paracetamol toxicity and works by replenishing glutathione levels, which helps neutralize the toxic metabolite NAPQI.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Antidotes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-07%20165208.jpg\" width=\"633\" height=\"750\"></strong></span></p>",
      "correct_choice_id": 293625,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73671/FMGE_Jan_2025_Pharmacology_Q_-_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/73671/FMGE_Jan_2025_Pharmacology_Q_-_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57649,
      "choices": [
        {
          "id": 229965,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an inherited red blood cell disorder causing intravascular hemolysis</span></span></p>"
        },
        {
          "id": 229966,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis of the disorder is confirmed by sucrose lysis test</span></span></p>"
        },
        {
          "id": 229967,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow cytometry is the gold standard for diagnosing this condition</span></span></p>"
        },
        {
          "id": 229968,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The commonest cause of mortality is cardiac failure</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a true/correct statement about paroxysmal nocturnal hemoglobinuria? (NEET PG 2024)</span></span></p>",
      "unique_key": "Q1900763",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979948,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Flow cytometry is the gold standard for diagnosing this condition</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, not inherited, clonal hematopoietic stem cell disorder that leads to red blood cell destruction (intravascular hemolysis), thrombosis, and bone marrow failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The gold standard for diagnosing PNH is flow cytometry, which detects the absence of GPI-anchored proteins (CD55 and CD59) on red blood cells, granulocytes, and monocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;The absence of these proteins makes cells vulnerable to complement-mediated destruction, characteristic of PNH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is an inherited red blood cell disorder causing intravascular hemolysis:</span></strong><span style=\"font-size:12.0pt\"> This statement is incorrect because PNH is not inherited but acquired due to a somatic mutation in the PIGA gene in hematopoietic stem cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The diagnosis of the disorder is confirmed by sucrose lysis test:</span></strong><span style=\"font-size:12.0pt\"> The sucrose lysis test is an older screening test for PNH but is not confirmatory. It has largely been replaced by flow cytometry, which is more accurate and specific for detecting the absence of CD55 and CD59.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The commonest cause of mortality is cardiac failure:</span></strong><span style=\"font-size:12.0pt\"> This statement is incorrect. The most common cause of mortality in PNH is thrombotic complications, especially hepatic vein thrombosis (Budd-Chiari syndrome), not cardiac failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow cytometry is the definitive test for diagnosing PNH by demonstrating the absence of CD55 and CD59 on blood cells.</span></span></p>",
      "correct_choice_id": 229967,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55760,
      "choices": [
        {
          "id": 222473,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardioversion</span></p>"
        },
        {
          "id": 222474,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine 0.3 mg per kg</span></p>"
        },
        {
          "id": 222475,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine 0.2 mg/kg</span></p>"
        },
        {
          "id": 222476,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine 0.1 mg/kg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old child with stable vitals and ECG showing PSVT. What is the appropriate management? (NEET PG 2024)</span></p>",
      "unique_key": "Q1166959",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979944,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Adenosine 0.1 mg/kg</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The management of paroxysmal supraventricular tachycardia (PSVT) in a stable child begins with pharmacological intervention rather than immediate cardioversion. Adenosine is the drug of choice for PSVT due to its ability to temporarily block the atrioventricular node, effectively terminating the arrhythmia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial dose of adenosine recommended is 0.1 mg/kg given as a rapid IV bolus over 1-3 seconds. If there is no response, subsequent doses can be increased to 0.2 mg/kg, and if necessary, 0.3 mg/kg can be administered under monitored conditions. Rapid bolus administration is essential, followed by a 5-10 ml of saline flush to ensure the drug reaches systemic circulation quickly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cardioversion:</strong> Cardioversion is typically reserved for cases where the patient is unstable or when pharmacological management fails. In a stable patient, the initial approach is to use adenosine to terminate the PSVT without the need for electrical intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adenosine 0.3 mg per kg:</strong> While this dosage of adenosine can be used if initial doses do not work, it is not the starting dose. The initial dose should be lower, at 0.1 mg/kg, to minimize potential adverse effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adenosine 0.2 mg/kg:</strong> This dose of adenosine is appropriate for a second attempt if the initial dose (0.1 mg/kg) does not resolve the PSVT. It is not the first-line dose but can be escalated to after the initial dose fails.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For stable PSVT in children, adenosine is the first-line treatment, starting at a dose of 0.1 mg/kg. If this dose is ineffective, the dose may be escalated in subsequent attempts.</span></p>",
      "correct_choice_id": 222476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6203,
      "choices": [
        {
          "id": 24781,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoxetine</span></p>"
        },
        {
          "id": 24782,
          "text": "<p><span style=\"font-size:12.0pt;\">Cognitive behavioral therapy</span></p>"
        },
        {
          "id": 24783,
          "text": "<p><span style=\"font-size:12.0pt;\">Lithium carbonate</span></p>"
        },
        {
          "id": 24784,
          "text": "<p><span style=\"font-size:12.0pt;\">Support and education</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the treatment of choice for postpartum blues?(NEET PG 2020)</span></p>",
      "unique_key": "Q8340177",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979957,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Support and education</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Postpartum blues (or \"baby blues\") is a mild, transient mood disturbance that affects up to 30-75% of postpartum women. Symptoms include mood lability, tearfulness, sadness, and sleep disturbances. It typically occurs within the first week (3-5 days) after delivery and resolves spontaneously within days to weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary management for postpartum blues is <strong>support and education</strong> about the condition, emphasizing its transient nature and differentiating it from the more severe postpartum depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Fluoxetine:</strong> Useful in postpartum depression but not needed for the milder blues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Cognitive behavioral therapy (CBT)</strong> can be beneficial for postpartum depression but is not the primary treatment for transient postpartum blues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Lithium carbonate:</strong> Not indicated for postpartum blues or depression; used mainly for bipolar disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Postpartum blues (or \"baby blues\") is a mild, transient mood disturbance that affects up to 30-75% of postpartum women. Symptoms include mood lability, tearfulness, sadness, and sleep disturbances. It typically occurs within the first week (3-5 days) after delivery and resolves spontaneously within days to weeks. Mainstay of management is reassurance, support, and education.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 839.</strong></span></p>",
      "correct_choice_id": 24784,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81069,
      "choices": [
        {
          "id": 322956,
          "text": "<p><span style=\"font-size:12.0pt;\">Type I</span></p>"
        },
        {
          "id": 322957,
          "text": "<p><span style=\"font-size:12.0pt;\">Type II</span></p>"
        },
        {
          "id": 322958,
          "text": "<p><span style=\"font-size:12.0pt;\">Type III</span></p>"
        },
        {
          "id": 322959,
          "text": "<p><span style=\"font-size:12.0pt;\">Type IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A fracture that involves the epiphysis, physis, and metaphysis is classified as which type of Salter-Harris fracture? (NEET PG 2016)</span></p>",
      "unique_key": "Q5332421",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979939,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Type IV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Salter-Harris Type IV fracture involves a vertical fracture line that extends from the articular surface through the epiphysis, across the growth plate (physis), and into the metaphysis. This is a complete fracture that traverses all three components - epiphysis, physis, and metaphysis. These fractures require precise anatomical reduction, usually through open reduction and internal fixation, as they have a high risk of growth disturbance if not properly aligned.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture9_cNAAsZ4.png\" width=\"664\" height=\"486\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Type I</strong>: This fracture involves only the growth plate (physis) with complete separation of the epiphysis from the metaphysis. The fracture line runs horizontally through the physis without involving either the epiphysis or metaphysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Type II</strong>: This fracture extends through the physis and partially into the metaphysis (creating the Thurston-Holland fragment), but does not involve the epiphysis. The epiphyseal surface remains intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Type III</strong>: This fracture extends vertically through the epiphysis and physis but stops at the metaphysis. It involves the articular surface but does not extend into the metaphysis, differentiating it from Type IV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Salter-Harris Type IV fractures are the only type that involve all three anatomical components (epiphysis, physis, and metaphysis) and therefore have a high risk of growth disturbance, requiring accurate reduction to prevent long-term complications.</span></p>",
      "correct_choice_id": 322959,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57606,
      "choices": [
        {
          "id": 229793,
          "text": "<p><span style=\"font-size:18px;\">BCG</span></p>"
        },
        {
          "id": 229794,
          "text": "<p><span style=\"font-size:18px;\">OPV</span></p>"
        },
        {
          "id": 229795,
          "text": "<p><span style=\"font-size:18px;\">DPT</span></p>"
        },
        {
          "id": 229796,
          "text": "<p><span style=\"font-size:18px;\">Rotaviral vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Vaccine kept at the lowest level inside an Ice lined refrigerator (ILR) at PHC: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
      "unique_key": "Q7841340",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979950,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) OPV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In an Ice Lined Refrigerator (ILR), which is commonly used at Primary Health Centers (PHCs) to store vaccines, the temperature varies from 2°C at the bottom to 8°C at the top. Vaccines that require colder temperatures, closer to 2°C, are stored at the lowest level of the refrigerator because cold air settles down.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>OPV (Oral Polio Vaccine)</strong>: OPV is stored at the lowest level of the ILR because it requires a colder environment. It can even tolerate freezing temperatures and can be stored in a deep freezer at -15°C to -25°C, making it suitable for the coldest section of the refrigerator.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Lyophilized vaccines</strong> like BCG, measles, and rotaviral vaccine are also stored at lower levels since they need a stable and colder temperature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174639.jpg\" alt=\"\" width=\"500\" height=\"397\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. BCG:</strong> While BCG is a lyophilized vaccine and is stored at a lower level, it is not specifically the answer for this question as OPV is more specifically associated with the lowest level due to its freezing tolerance.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. DPT:</strong> DPT vaccine is stored at the upper levels of the ILR where temperatures are closer to 6-8°C. This vaccine does not require the colder conditions found at the bottom of the refrigerator.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Rotaviral vaccine:</strong> Similar to BCG, the rotaviral vaccine is a lyophilized vaccine stored lower in the ILR, but OPV is the more critical vaccine stored at the lowest level due to its requirement for cold and even freezing conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">OPV is stored at the lowest level of the ILR due to its requirement for the coldest storage conditions, ranging from 2°C and even tolerating freezing conditions, ensuring vaccine potency and effectiveness.</span></p>",
      "correct_choice_id": 229794,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73633,
      "choices": [
        {
          "id": 293473,
          "text": "<p><span style=\"font-size:16px;\">Keratoacanthoma</span></p>"
        },
        {
          "id": 293474,
          "text": "<p><span style=\"font-size:16px;\">Melanocytic melanoma</span></p>"
        },
        {
          "id": 293475,
          "text": "<p><span style=\"font-size:16px;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 293476,
          "text": "<p><span style=\"font-size:16px;\">Basal cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man presents with an ulcerative lesion near the medial canthus of his eye, featuring pearly margins. Microscopic examination reveals a palisading arrangement of cells, along with keratin pearls. What is the most likely diagnosis? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q3132947",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979960,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Basal cell carcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of an ulcerative lesion with pearly margins in the medial canthus (inner corner) of the eye is highly characteristic of <strong>basal cell&nbsp;carcinoma (BCC).</strong> This location is a common site for BCC, which is also known as <strong>\"rodent ulcer\" or \"tear cancer\"</strong> due to its predilection for the periocular region. The microscopic finding of <strong>palisading arrangement of cells is a hallmark feature of BCC,</strong> where the peripheral cells arrange themselves in a palisade-like pattern.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Keratoacanthoma:&nbsp;</strong>Incorrect. While keratoacanthoma may present as an ulcerative lesion, it typically has a central keratin-filled crater rather than pearly margins. It usually grows rapidly over a few weeks and is most commonly found on sun-exposed areas like the face, forearms, and hands. It lacks the characteristic palisading arrangement seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Melanocytic melanoma:&nbsp;</strong>Incorrect. Melanoma presents as a pigmented lesion with irregular borders and color variations. It does not typically have pearly margins or palisading arrangement of cells on microscopy<strong>.</strong> Instead, it shows atypical melanocytes with nuclear pleomorphism and invasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Squamous cell carcinoma:</strong> Incorrect. While squamous cell carcinoma can present as an ulcerative lesion and does feature keratin pearls microscopically, it typically lacks the pearly margins described in this case. Additionally, the palisading arrangement of cells is not characteristic of squamous cell carcinoma but is a hallmark feature of basal cell carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Basal cell carcinoma presenting as an ulcerative lesion with pearly margins (rodent ulcer) is characteristic, especially in the periocular region, with microscopic findings of peripheral palisading arrangement of basaloid cells.</span></p>",
      "correct_choice_id": 293476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55434,
      "choices": [
        {
          "id": 221197,
          "text": "<p><span style=\"font-size:18px;\">K+</span></p>"
        },
        {
          "id": 221198,
          "text": "<p><span style=\"font-size:18px;\">Na+</span></p>"
        },
        {
          "id": 221199,
          "text": "<p><span style=\"font-size:18px;\">HCO<sub>3</sub>-</span></p>"
        },
        {
          "id": 221200,
          "text": "<p><span style=\"font-size:18px;\">Cl-</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Oxygen sensitive channels in peripheral chemoreceptors are for which of the following ion? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q1971517",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979941,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) K+</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Peripheral chemoreceptors are specialized sensory receptors located in the carotid and aortic bodies that detect changes in blood oxygen levels. These receptors play a critical role in the respiratory control by responding to hypoxia (low oxygen levels). The oxygen-sensitive channels in these receptors are specifically sensitive to potassium ions (K+). When oxygen levels drop, these potassium channels close, which leads to a series of events: membrane depolarization, calcium influx, and ultimately, the release of neurotransmitters like ATP. This process triggers signals that increase respiratory activity to raise blood oxygen levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Na+:&nbsp;</strong>Sodium channels are important in many physiological processes, but they are not specifically sensitive to oxygen levels in peripheral chemoreceptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. HCO<sub>3</sub>-:&nbsp;</strong>Bicarbonate ions are involved in acid-base balance and CO<sub>2</sub> transport but are not directly involved in the oxygen sensing mechanism of peripheral chemoreceptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Cl-:&nbsp;</strong>Chloride ions play roles in various cellular processes, including maintaining osmotic balance, but they are not the primary ions involved in oxygen sensing in peripheral chemoreceptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The primary ion involved in oxygen sensing in peripheral chemoreceptors is potassium (K+). The closure of oxygen-sensitive potassium channels during hypoxia is a crucial step in the signaling pathway that regulates respiratory response to low oxygen levels.</span></p>",
      "correct_choice_id": 221197,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57603,
      "choices": [
        {
          "id": 229781,
          "text": "<p><span style=\"font-size:18px;\">Silicosis</span></p>"
        },
        {
          "id": 229782,
          "text": "<p><span style=\"font-size:18px;\">Byssinosis</span></p>"
        },
        {
          "id": 229783,
          "text": "<p><span style=\"font-size:18px;\">Bagassosis</span></p>"
        },
        {
          "id": 229784,
          "text": "<p><span style=\"font-size:18px;\">Lead poisoning</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A person reported to OPD alongside his 32-year-old brother working in a factory. The brother was recently subjected to a test – Coproporphyrin in urine. The physician should suspect: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
      "unique_key": "Q3869289",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979947,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Lead poisoning</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The presence of coproporphyrin in urine is commonly associated with lead exposure, making it an important <strong>screening test for lead poisoning</strong>. Coproporphyrin in urine indicates exposure to lead, but it does not confirm whether significant absorption has occurred. To determine absorption, a specific diagnostic test called Aminolevulinic Acid in Urine (ALAU) is used.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">CPU – screening test – indicates lead Exposure - &gt;150 mcg/L</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">ALAU – diagnostic test – indicated lead absorption - &gt; 5mg/L</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Elevated levels of lead in urine (&gt;800 µg/L) signify both exposure and absorption, while levels above 700 µg/L indicate the onset of clinical symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Lead poisoning, also known as plumbism, is treated with chelation therapy using EDTA combined with dimercaprol, which helps remove lead from the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Silicosis: </strong>Silicosis is a lung disease caused by inhaling silica dust, common in mining, quarrying, and glass manufacturing industries. It does not involve testing for coproporphyrin in urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Byssinosis: </strong>Byssinosis, also known as “brown lung disease,” is caused by inhaling cotton, flax, or hemp dust, mainly affecting textile workers. It is unrelated to coproporphyrin levels in urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Bagassosis: </strong>Bagassosis is an occupational lung disease caused by inhaling dust from bagasse, the fibrous residue of sugarcane. This condition is not associated with lead exposure or coproporphyrin levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">Coproporphyrin in urine is an important screening test for lead poisoning, indicating exposure to lead, and should be followed by diagnostic tests to assess absorption.</span></p>",
      "correct_choice_id": 229784,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51453,
      "choices": [
        {
          "id": 205329,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits DNA gyrase</span></span></p>"
        },
        {
          "id": 205330,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits topoisomerase II</span></span></p>"
        },
        {
          "id": 205331,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits dihydrofolic acid reductase</span></span></p>"
        },
        {
          "id": 205332,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkylates DNA</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is undergoing treatment for cancer with methotrexate. What is the mechanism of action? (FMGE JULY 2024)</span></span></p>",
      "unique_key": "Q8190547",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979942,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Inhibits dihydrofolic acid reductase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methotrexate works by inhibiting the enzyme dihydrofolic acid reductase (DHFR). DHFR is crucial in converting dihydrofolic acid to tetrahydrofolic acid, a necessary cofactor in DNA synthesis. By blocking DHFR, methotrexate prevents the production of tetrahydrofolic acid, ultimately disrupting DNA synthesis and cell division. This makes it effective against rapidly dividing cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Inhibits DNA gyrase:</span></strong><span style=\"font-size:12.0pt\"> DNA gyrase is an enzyme involved in DNA replication and repair. While inhibiting it would also disrupt cell division, it is not the primary target of methotrexate.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Inhibits topoisomerase II:</span></strong><span style=\"font-size:12.0pt\"> Topoisomerase II is another enzyme involved in DNA replication. It is targeted by some anticancer drugs, but not methotrexate.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Alkylates DNA:</span></strong><span style=\"font-size:12.0pt\"> Alkylating agents work by directly damaging DNA, leading to cell death. Methotrexate does not alkylate DNA; its action is more indirect through inhibiting DHFR.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate is an antimetabolite drug that inhibits dihydrofolic acid reductase, an enzyme crucial for DNA synthesis. This mechanism disrupts cell division, making it effective in treating cancer.</span></span></p>",
      "correct_choice_id": 205331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10244,
      "choices": [
        {
          "id": 40942,
          "text": "<p><span style=\"font-size:18px;\">Candela</span></p>"
        },
        {
          "id": 40943,
          "text": "<p><span style=\"font-size:18px;\">Lux</span></p>"
        },
        {
          "id": 40944,
          "text": "<p><span style=\"font-size:18px;\">Lambert</span></p>"
        },
        {
          "id": 40945,
          "text": "<p><span style=\"font-size:18px;\">Lumen</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>What is the SI unit used to measure the brightness of light from a point source among the options provided? </strong><i><strong>[NEET PG 2021]</strong></i></span></p>",
      "unique_key": "Q3759355",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979951,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Candela</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The candela is the SI unit used to measure the brightness (luminous intensity) of a light source emitting light in a specific direction. It quantifies the amount of light emitted from a point source within a solid angle of one steradian.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong>&nbsp;<strong>Lux: Usage:</strong> Measures illumination or illuminance.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Definition:</strong> It quantifies the amount of light reaching a surface. One lux is equal to one lumen per square meter.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong>&nbsp;<strong>Lambert: Usage:</strong> Measures brightness or luminance.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Definition:</strong> It quantifies the amount of light emitted by a surface. One lambert is equal to the luminance of a surface emitting or reflecting one lumen per square centimeter.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>Lumen: Usage:</strong> Measures luminous flux.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Definition:</strong> It quantifies the total amount of visible light emitted by a source. One lumen is the luminous flux emitted within a solid angle of one steradian by a point source with a luminous intensity of one candela.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-143708.png\" alt=\"\" width=\"1000\" height=\"442\"></strong></span></p>",
      "correct_choice_id": 40942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5869,
      "choices": [
        {
          "id": 23446,
          "text": "<p><span style=\"font-size:12pt;\">Intensity is inversely proportional to squared distance</span></p>"
        },
        {
          "id": 23447,
          "text": "<p><span style=\"font-size:12pt;\">Small blood vessels are most radioresistant</span></p>"
        },
        {
          "id": 23448,
          "text": "<p><span style=\"font-size:12pt;\">Rapidly proliferating cells are most radioresistant</span></p>"
        },
        {
          "id": 23449,
          "text": "<p><span style=\"font-size:12pt;\">Small bowel is most radioresistant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with endometrial carcinoma is undergoing radiotherapy. Which of the following is true?&nbsp;</span>(NEET PF 2020)</p>",
      "unique_key": "Q9964437",
      "question_audio": null,
      "question_video": null,
      "map_id": 25979953,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Intensity is inversely proportional to squared distance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This statement refers to the Inverse Square Law, which states that the intensity of radiation is inversely proportional to the square of the distance from the source. This means that as the distance from the radiation source increases, the intensity of the radiation decreases exponentially. This law is fundamental in radiation physics and is crucial for understanding radiation exposure and protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Small blood vessels are most radioresistant:</strong> This is incorrect. Larger vessels are more radioresistant compared to smaller ones. The endothelial cells lining small vessels are more susceptible to radiation damage due to their relatively higher rate of proliferation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rapidly proliferating cells are most radioresistant:</strong> This is incorrect. Rapidly proliferating cells are the most radiosensitive. Cells that are dividing quickly, such as those in the gastrointestinal tract, bone marrow, and reproductive tissues, are more susceptible to radiation damage because radiation primarily affects DNA during cell division.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Small bowel is most radioresistant:</strong> This is incorrect. The gastrointestinal (GI) tract, including the small bowel, is among the most radiosensitive organ systems in the body. This high radiosensitivity is due to the rapid turnover of the epithelial cells lining the GI tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The intensity of radiation is inversely proportional to the square of the distance from the source, as described by the Inverse Square Law.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 610, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 23446,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}